IL6 and COVID-19: - The large variability of the degree of systemic inflammation in patient cohort (different baseline concentrations for IL-6.)- Small sample size does not allow meaningful sub-group analyses- Inferences about cytokine adsorption for shorter or longer periods during ECMO support in COVID-19 nor about cytokine adsorption at different timepoints during the course of the disease was not allowed